- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Results
4
Undervalued Small Caps
4 companies
CanSino Biologics
Market Cap: HK$13.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.74
7D
-0.9%
1Y
10.2%
Consun Pharmaceutical Group
Market Cap: HK$14.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$17.02
7D
-0.3%
1Y
81.8%
Medtide
Market Cap: HK$3.2b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$22.56
7D
1.9%
1Y
n/a
Viva Biotech Holdings
Market Cap: HK$4.1b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.95
7D
-1.0%
1Y
43.4%